---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-025405"
form_type: "8-K"
ticker: "DRMA"
cik: "0001853816"
company_name: "Dermata Therapeutics, Inc."
filed_at: "2025-08-25T23:59:59+00:00"
generated_at: "2026-05-17T10:19:46.284673+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Dermata Therapeutics regains Nasdaq minimum bid price compliance

## Summary
- Received Nasdaq non-compliance notice on May 14, 2025 due to bid price below $1.00.
- Requested hearing; granted exception until August 14, 2025 to demonstrate compliance.
- On August 22, 2025, staff confirmed compliance with Minimum Bid Price Requirement; matter closed.
- Common stock (DRMA) and warrants (DRMAW) remain listed on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001641172-25-025405
- form_type: 8-K
- ticker: DRMA
- cik: 0001853816
- company_name: Dermata Therapeutics, Inc.
- filed_at: 2025-08-25T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1853816/000164117225025405/0001641172-25-025405-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1853816/000164117225025405/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-025405
- JSON: https://secwatch.observer/filing/0001641172-25-025405.json
- Plain text: https://secwatch.observer/filing/0001641172-25-025405.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.